Profund Advisors LLC Sage Therapeutics, Inc. Transaction History

Profund Advisors LLC

$2.59 Billion
Q3 2024

A detailed history of Profund Advisors LLC transactions in Sage Therapeutics, Inc. stock. As of the latest transaction made, Profund Advisors LLC holds 29,348 shares of SAGE stock, worth $159,653. This represents 0.01% of its overall portfolio holdings.

Number of Shares

29,348

Previous 22,959 27.83%

Holding current value

$159,653

Previous $249,000 15.26%

% of portfolio

0.01%

Previous 0.01%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$7.02 - $13.08 $44,850 - $83,568	6,389 Added 27.83%	29,348 $211,000
Q2 2024 Aug 13, 2024	SELL	$10.58 - $17.9 $398,061 - $673,469	-37,624 Reduced 62.1%	22,959 $249,000
Q1 2024 May 08, 2024	BUY	$18.62 - $26.95 $202,399 - $292,946	10,870 Added 21.87%	60,583 $1.14 Million
Q4 2023 Feb 14, 2024	SELL	$17.1 - $22.26 $325,618 - $423,874	-19,042 Reduced 27.7%	49,713 $1.08 Million
Q3 2023 Nov 13, 2023	BUY	$16.75 - $48.98 $721,523 - $2.11 Million	43,076 Added 167.75%	68,755 $1.41 Million
Q2 2023 Aug 10, 2023	SELL	$40.65 - $59.54 $222,152 - $325,386	-5,465 Reduced 17.55%	25,679 $1.21 Million
Q1 2023 May 11, 2023	BUY	$37.27 - $46.57 $1.16 Million - $1.45 Million	31,144 New	31,144 $1.31 Million
Q3 2020 Nov 13, 2020	SELL	$41.13 - $62.45 $473,282 - $718,612	-11,507 Closed	0 $0
Q2 2020 Aug 03, 2020	BUY	$25.95 - $43.15 $45,827 - $76,202	1,766 Added 18.13%	11,507 $478,000
Q1 2020 May 15, 2020	SELL	$26.15 - $77.24 $92,754 - $273,970	-3,547 Reduced 26.69%	9,741 $280,000
Q4 2019 Feb 18, 2020	BUY	$60.18 - $154.77 $84,312 - $216,832	1,401 Added 11.79%	13,288 $959,000
Q3 2019 Nov 12, 2019	SELL	$140.29 - $189.96 $100,026 - $135,441	-713 Reduced 5.66%	11,887 $1.67 Million
Q2 2019 Aug 13, 2019	SELL	$157.85 - $183.09 $219,885 - $255,044	-1,393 Reduced 9.95%	12,600 $2.31 Million
Q1 2019 May 15, 2019	BUY	$89.33 - $163.65 $100,674 - $184,433	1,127 Added 8.76%	13,993 $2.23 Million
Q4 2018 Feb 14, 2019	SELL	$81.94 - $139.71 $254,095 - $433,240	-3,101 Reduced 19.42%	12,866 $1.23 Million
Q3 2018 Nov 13, 2018	BUY	$138.11 - $169.04 $2.21 Million - $2.7 Million	15,967 New	15,967 $2.26 Million

Others Institutions Holding SAGE

# of Institutions

198

Shares Held

46.5M

Call Options Held

402K

Put Options Held

209K

View Full List

About Sage Therapeutics, Inc.

Ticker SAGE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,422,300
Market Cap $323M
Description
Sage Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines to treat central nervous system disorders. Its lead product candidate is ZULRESSO, an intravenous formulation of brexanolone for the treatment of postpartum depression (PPD) in adults. The company's product pipeline also includes zuranolone, a neuroactive...

More about SAGE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Profund Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Profund Advisors LLC with notifications on news.

Account

Profund Advisors LLC Sage Therapeutics, Inc. Transaction History